Journal article

Virtual guidance: Mood disorders guidelines '2. Oh'!

Gin S Malhi, Erica Bell, Darryl Bassett, Philip Boyce, Malcolm Hopwood, Greg Murray, Richard Porter, Ajeet Singh, Roger Mulder

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | SAGE PUBLICATIONS LTD | Published : 2021

University of Melbourne Researchers

Grants

Funding Acknowledgements

The author(s) declared the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: G.S.M. has received grant or research support from National Health and Medical Research Council, Australian Rotary Health, NSW Health, American Foundation for Suicide Prevention, Ramsay Research and Teaching Fund, Elsevier, AstraZeneca, Janssen-Cilag, Lundbeck, Otsuka and Servier; and has been a consultant for AstraZeneca, Janssen-Cilag, Lundbeck, Otsuka and Servier. D.B. has received funding to host webinars by Lundbeck. P.B. has received research support from the National Health and Medical Research Council; speaker fees from Servier, Janssen and the Australian Medical Forum; and educational support from Servier and Lundbeck; has been a consultant for Servier; served on an advisory board for Lundbeck; and has served as DSMC Chair for Douglas Pharmaceuticals. R.M. has received support for travel to education meetings from Servier and Lundbeck, and speaker fees from Servier and Committee fees from Janssen. G.M. has received grant support in the last 5 years from the National Health and Medical Research Council, the Mental Illness Research Fund, Victorian Medical Research Acceleration Fund, Canadian Institutes of Health Research, Readiness, SiSU Wellness and Barbara Dicker Foundation. M.H. has received grant or research support in the last 5 years from the National Health and Medical Research Council, Medical Research Future Fund, Ramsay Health Research Foundation, Boehringer-Ingleheim, Douglas, Janssen-Cilag, Lundbeck, Lyndra, Otsuka, Praxis and Servier; and has been a consultant for Janssen-Cilag, Lundbeck, Otsuka and Servier. A.S. has shares/options in Baycrest Biotechnology Pty Ltd (pharmacogenetics company) and Greenfield Medicinal Cannabis, and has received speaking honoraria from Servier, Lundbeck and Otsuka Australia. R.P. has received support for travel to educational meetings from Servier and Lundbeck and uses software for research at no cost from Scientific Brain Training Pro. The author E.B. declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.